Immune Effects of Vitamin D in Hemodialysis Patients

NCT00686751 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

End Stage Renal Disease
Hemodialysis
Inflammatory Response
Cardiovascular Disease

Interventions

DRUG: paricalcitol

Sponsor

Renal Research Institute

Collaborators

[object Object]